Bottom line
JDOC vs TRUH: the short answer
JDOC (JPMorgan Healthcare Leaders ETF) and TRUH (VanEck Healthcare TruSector ETF) share a meaningful slice of their top holdings — about 62% by weight.
TRUH is cheaper at 0.1% vs 0.65% — a difference of $55 a year per $10,000 invested.
Updated Nov 19, 2026
JDOC vs TRUH side by side
| JDOC | TRUH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | J.P. Morgan | VanEck |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.65% | 0.1% |
| Annual cost per $10k | $65 | $10 |
| 10-yr cost on $10k (prospectus) | $810 | — |
| Max front load | None | None |
| 12b-1 fee | — | — |
| 1-yr return | +14.9% | — |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +11.3% | — |
| Worst quarter | −11.9% | — |
| Net assets (fund) | $9.1M | $833.1K |
| Number of holdings | 61 | 60 |
| Portfolio turnover | 92% | — |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
15 of JDOC's top 25 holdings also appear in TRUH's top 25.
| Holding | JDOC | TRUH |
|---|---|---|
| AbbVie, Inc. | 7.85% | 7.76% |
| Eli Lilly & Co. | 7.76% | 16.56% |
| UnitedHealth Group, Inc. | 5.85% | 6.59% |
| Merck & Co., Inc. | 4.82% | 5.54% |
| Johnson & Johnson | 4.82% | 10.67% |
| Thermo Fisher Scientific, Inc. | 3.73% | 3.25% |
| Bristol-Myers Squibb Co. | 3.57% | 2.05% |
| Abbott Laboratories | 3.11% | 2.76% |
| CVS Health Corp. | 2.83% | 2.31% |
| Stryker Corp. | 2.23% | 1.89% |
| Danaher Corp. | 2.16% | 2.10% |
| Cencora, Inc. | 2.07% | 0.95% |
| Intuitive Surgical, Inc. | 1.93% | 2.48% |
| Regeneron Pharmaceuticals, Inc. | 1.60% | 1.12% |
| Cardinal Health, Inc. | 1.51% | 0.97% |
Source: SEC Form N-PORT
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
TRUH top 10
- Eli Lilly & Co — 16.56%
- Johnson & Johnson — 10.67%
- AbbVie Inc — 7.76%
- UnitedHealth Group Inc — 6.59%
- Merck & Co Inc — 5.54%
- Amgen Inc — 3.39%
- Thermo Fisher Scientific Inc — 3.25%
- Abbott Laboratories — 2.76%
- Gilead Sciences Inc — 2.74%
- Intuitive Surgical Inc — 2.48%
FAQ
What is the difference between JDOC and TRUH?
JDOC (JPMorgan Healthcare Leaders ETF) and TRUH (VanEck Healthcare TruSector ETF) share a meaningful slice of their top holdings — about 62% by weight. TRUH is cheaper at 0.1% vs 0.65% — a difference of $55 a year per $10,000 invested.
Which is cheaper, JDOC or TRUH?
TRUH has the lower expense ratio (0.1%).
Should I own both JDOC and TRUH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.